VitalSigns
Return to the Blog Homepage

Tag Archives: FDA approval process

Med-Sci Matters by Dr. Dave

This installment has a somewhat unusual collection of topics – how a recent FDA approval may augur a paradigm shift in the drug review process by giving more weight to patient points of view, drug pricing, FDA hearings on disseminating off-label drug...

Med-Sci Matters by Dr. Dave

1. Calls for Greater Data Sharing The current issue of NEJM includes a series of perspectives articles advocating for greater data sharing among pharma companies, academic institutions and the government. One of the pieces is by Sen Elizabeth Warren, who...